GGrantIndex
Sort

35,931 grants matching parkinsons

Identifying novel Parkinson'’s disease genes exploring understudied Latino populations

$623,428
Ignacio Fernandez Mata · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · NS

More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease and Lewy Body Dementias

$623,306
Benzi M Kluger · University Of Rochester · R01 · FY2022 · NR

Optimization of ultrasound-facilitated blood-brain barrier opening

$623,304
Elisa E Konofagou · Columbia University Health Sciences · R01 · FY2017 · EB

DERIVATION AND SAFETY TESTING OF NON-HUMAN PRIMATE EMBRYONIC GERM CELL LINES

$623,298
Peter John Donovan · Magee-Women'S Res Inst And Foundation · P01 · FY2008 · HD

Neuronal FXR as a potential therapeutic target for Alzheimer's disease

$623,202
Julie Kay Andersen · Buck Institute For Research On Aging · R01 · FY2022 · AG

4D Transcranial Acoustoelectric Imaging for High Resolution Functional Mapping of Neuronal Currents

$623,077
Russell S Witte · University Of Arizona · U01 · FY2024 · EB

Focal Dopamine Indicated in Dyskinesias in MPTP Monkeys

$622,963
Krystof S Bankiewicz · University Of California, San Francisco · R01 · FY2007 · NS

Gut Microbiota Underlies the Heterogeneity of Aging Brain's Susceptibility to Postoperative Delirium

$622,824
Shiqian Shen · Massachusetts General Hospital · R01 · FY2025 · AG

Mobile Decision Support System for Nurse Management of Neuromodulation Therapy

$622,658
Christopher R Butson · University Of Utah · R01 · FY2015 · NR

ENIGMA Parkinson’s Initiative: A Global Initiative for Parkinson’s Disease

$622,599
Paul M Thompson · University Of Southern California · R01 · FY2023 · NS

Role of reactive astrocytes in prion diseases

$622,545
Ilia V Baskakov · University Of Maryland Baltimore · R01 · FY2023 · NS

Role of reactive astrocytes in prion diseases

$622,545
Ilia V Baskakov · University Of Maryland Baltimore · R01 · FY2025 · NS

Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases

$622,539
Pembe Hande Ozdinler · Northwestern University At Chicago · R01 · FY2021 · AG

Effects of Parkinson's Disease on Perception, Cognition, and Gait

$622,409
Alice M. Cronin-Golomb · Boston University (Charles River Campus) · R01 · FY2012 · NS

Regional Brain Manganese Accumulation and Functional Consequences in Welders

$622,357
Xuemei Huang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2014 · ES

Impact of Anticholinergic and Dopamine Receptor Blocking Drug Exposure on Parkinson Disease Trajectory and Outcomes

$622,201
Allison Willis · University Of Pennsylvania · R01 · FY2018 · NS

ENIGMA Parkinson’s Initiative: A Global Initiative for Parkinson’s Disease

$622,162
Paul M Thompson · University Of Southern California · R01 · FY2025 · NS

Neuronal FXR as a potential therapeutic target for Alzheimer's disease

$622,119
Julie Kay Andersen · Buck Institute For Research On Aging · R01 · FY2021 · AG

Digital Markers of Mobility in Daily Life to Track Progression in Newly Diagnosed Parkinson's Disease

$622,056
Martina Mancini · Oregon Health & Science University · R01 · FY2022 · AG

TRAINING GRANT ON THE BIOLOGY OF AGING

$621,983
Steven N. Austad · University Of Texas Hlth Science Center · T32 · FY2009 · AG

Towards Therapeutics for Neurodegenerative Diseases

$621,851
Stanley B Prusiner · University Of California, San Francisco · R37 · FY2014 · AG

Bright light modulation of non-motor symptoms in Parkinson's disease

$621,838
Aleksandar Videnovic · Massachusetts General Hospital · R01 · FY2020 · NS

Bright light modulation of non-motor symptoms in Parkinson's disease

$621,838
Aleksandar Videnovic · Massachusetts General Hospital · R01 · FY2018 · NS

Bright light modulation of non-motor symptoms in Parkinson's disease

$621,838
Aleksandar Videnovic · Massachusetts General Hospital · R01 · FY2019 · NS

Development Of New Approaches To Neuroimaging with PET and SPECT

$621,828
Elliot Stein · National Institute On Drug Abuse · Z01 · FY2007 · DA